Opinion by Nick Valeriani
When I became the chief executive of West Health after 34 years at Johnson & Johnson, I asked my new colleagues why any company would give up the competitive advantage of a proprietary system. Having served as J&J’s worldwide chairman of Medical Devices & Diagnostics, I couldn’t imagine why any company would do so. I’ve since been convinced that the benefits of an open system far outweigh any competitive advantage of a closed one. I truly believe that an interoperable healthcare system will result in enhanced patient safety and improved clinical outcomes at a lower cost.